These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 22950415)
21. Classification of segmental vitiligo on the trunk. van Geel N; Bosma S; Boone B; Speeckaert R Br J Dermatol; 2014 Feb; 170(2):322-7. PubMed ID: 24117138 [TBL] [Abstract][Full Text] [Related]
22. Late onset vitiligo: a study of 182 patients. Dogra S; Parsad D; Handa S; Kanwar AJ Int J Dermatol; 2005 Mar; 44(3):193-6. PubMed ID: 15807724 [TBL] [Abstract][Full Text] [Related]
23. Early-onset childhood vitiligo is associated with a more extensive and progressive course. Mu EW; Cohen BE; Orlow SJ J Am Acad Dermatol; 2015 Sep; 73(3):467-70. PubMed ID: 26118892 [TBL] [Abstract][Full Text] [Related]
24. New discoveries in the pathogenesis and classification of vitiligo. Rodrigues M; Ezzedine K; Hamzavi I; Pandya AG; Harris JE; J Am Acad Dermatol; 2017 Jul; 77(1):1-13. PubMed ID: 28619550 [TBL] [Abstract][Full Text] [Related]
25. Distribution patterns in generalized vitiligo. Speeckaert R; van Geel N J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):755-62. PubMed ID: 23651011 [TBL] [Abstract][Full Text] [Related]
27. Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia. Alissa A; Al Eisa A; Huma R; Mulekar S Saudi Med J; 2011 Dec; 32(12):1291-6. PubMed ID: 22159386 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and Clinical Characteristics of Itch in Vitiligo and Its Clinical Significance. Vachiramon V; Onprasert W; Harnchoowong S; Chanprapaph K Biomed Res Int; 2017; 2017():5617838. PubMed ID: 28828385 [TBL] [Abstract][Full Text] [Related]
29. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. Shin J; Lee JS; Hann SK; Oh SH Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270 [TBL] [Abstract][Full Text] [Related]
30. Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo. Benzekri L; Gauthier Y; Hamada S; Hassam B Br J Dermatol; 2013 Feb; 168(2):265-71. PubMed ID: 22963656 [TBL] [Abstract][Full Text] [Related]
31. Factors Associated with Development of Vitiligo in Patients with Halo Nevus. Zhou H; Wu LC; Chen MK; Liao QM; Mao RX; Han JD Chin Med J (Engl); 2017 Nov; 130(22):2703-2708. PubMed ID: 29133759 [TBL] [Abstract][Full Text] [Related]
33. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Ezzedine K; Lim HW; Suzuki T; Katayama I; Hamzavi I; Lan CC; Goh BK; Anbar T; Silva de Castro C; Lee AY; Parsad D; van Geel N; Le Poole IC; Oiso N; Benzekri L; Spritz R; Gauthier Y; Hann SK; Picardo M; Taieb A; Pigment Cell Melanoma Res; 2012 May; 25(3):E1-13. PubMed ID: 22417114 [TBL] [Abstract][Full Text] [Related]
34. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Augustin M; Gajur AI; Reich C; Rustenbach SJ; Schaefer I Dermatology; 2008; 217(2):101-6. PubMed ID: 18451647 [TBL] [Abstract][Full Text] [Related]
35. Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo. Kroon MW; Joore IC; Wind BS; Leloup MA; Wolkerstorfer A; Luiten RM; Bos JD; Geskus RB; van der Veen JP Br J Dermatol; 2012 Mar; 166(3):532-8. PubMed ID: 22050082 [TBL] [Abstract][Full Text] [Related]
36. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735 [TBL] [Abstract][Full Text] [Related]
37. Late onset vitiligo and audiological abnormalities: is there any association? Al-Mutairi N; Al-Sebeih KH Indian J Dermatol Venereol Leprol; 2011; 77(5):571-6. PubMed ID: 21860155 [TBL] [Abstract][Full Text] [Related]
38. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo. Agarwal S; Ramam M; Sharma VK; Khandpur S; Pal H; Pandey RM Br J Dermatol; 2005 Jul; 153(1):163-6. PubMed ID: 16029343 [TBL] [Abstract][Full Text] [Related]
39. [Vitiligo and Koebner phenomenon following platelet-rich plasma injections]. Ejjiyar M; Sahibi M; El Gueouatri M; Bhihi A; Mahrouch M; Yafi I; El Amrani MD; Benchamkha Y Pan Afr Med J; 2019; 32():58. PubMed ID: 31223350 [TBL] [Abstract][Full Text] [Related]
40. Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study. van Geel N; Depaepe L; Speeckaert R J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1121-7. PubMed ID: 25286980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]